148 related articles for article (PubMed ID: 12749010)
1. Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia.
Steinberger BA; Ford SM; Coleman TA
Am J Hematol; 2003 Jun; 73(2):97-100. PubMed ID: 12749010
[TBL] [Abstract][Full Text] [Related]
2. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
3. True hyponatremia secondary to intravenous immunoglobulin.
Nguyen MK; Rastogi A; Kurtz I
Clin Exp Nephrol; 2006 Jun; 10(2):124-6. PubMed ID: 16791398
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure.
Bentley P; Rosso M; Sadnicka A; Israeli-Korn S; Laffan M; Sharma P
J Clin Pharm Ther; 2012 Jun; 37(3):286-90. PubMed ID: 21767284
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events.
Dalakas MC
Neurology; 1994 Feb; 44(2):223-6. PubMed ID: 8309562
[TBL] [Abstract][Full Text] [Related]
7. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin, blood viscosity and myocardial infarction.
Fisman DN; Smilovitch M
Can J Cardiol; 1997 Aug; 13(8):775-7. PubMed ID: 9284845
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
12. Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders.
Kowal P; Zmyślony A
Clin Hemorheol Microcirc; 2008; 40(3):229-34. PubMed ID: 19029646
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of interleukin-6 and interleukin-10 in patients with multiple sclerosis during intravenous immunoglobulin infusion].
Kazibutowska Z; Motta E; Huć M; Strzała-Orzeł M; Woźnik G
Wiad Lek; 2006; 59(9-10):626-9. PubMed ID: 17338118
[TBL] [Abstract][Full Text] [Related]
14. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.
Hefer D; Jaloudi M
Ann Hematol; 2004 Oct; 83(10):661-5. PubMed ID: 15309520
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced hyponatremia.
Norman NE; Sneed AM; Brown C; Ellis CA; Minard G; Brown RO
Ann Pharmacother; 2004 Mar; 38(3):404-7. PubMed ID: 14742828
[TBL] [Abstract][Full Text] [Related]
17. Pseudohyponatremia in multiple myeloma.
Vaswani SK; Sprague R
South Med J; 1993 Feb; 86(2):251-2. PubMed ID: 8434306
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease.
Chrissafidou A; Malek M; Musch E
Z Gastroenterol; 2007 Jul; 45(7):605-8. PubMed ID: 17620224
[TBL] [Abstract][Full Text] [Related]
19. Diffuse venous thromboemboli associated with IVIg therapy in the treatment of streptococcal toxic shock syndrome: case report and review.
Geller JL; Hackner D
Ann Hematol; 2005 Sep; 84(9):601-4. PubMed ID: 15815906
[TBL] [Abstract][Full Text] [Related]
20. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
